# A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment

> **NCT01571388** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 25 (actual)

## Conditions studied

- Healthy
- Otherwise Healthy Volunteers With Mild or Moderate Hepatic Dysfunction

## Interventions

- **DRUG:** dacomitinib
- **DRUG:** dacomitinib
- **DRUG:** dacomitinib

## Key facts

- **NCT ID:** NCT01571388
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571388, "A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01571388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*